Irenic Capital Management’s Vigil Neuroscience VIGL Stock Holding History

Irenic Capital Management’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-371,321	Closed	-$2.95M	–	28
2025 Q2	$2.95M	Buy	+371,321	New	+$1.66M	0.44%	18

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Irenic Capital Management's VIGL Position: Q3 2025 in Review

Irenic Capital Management sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 371,321 shares — an estimated $2.95M sold.

Irenic Capital Management first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $2.95M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Irenic Capital Management reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Irenic Capital Management sold 371,321 Vigil Neuroscience shares in Q3 2025, an estimated $2.95M.
Irenic Capital Management first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Irenic Capital Management's Vigil Neuroscience position peaked at $2.95M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Irenic Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.